Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

Hympavzi is now approved in the U.K. for the prevention of bleeds in adults and adolescents with hemophilia A or B, without ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Report Ocean (150+ country’s markets analyzed, function on 1,00000+ published and forthcoming reports every year.] presents a research report and top winning strategies for the “ Blood Plasma ...

Bridging these proteins it helps restore clotting function in individuals with hemophilia A ... Marstacimab (PF-06741086) is ...